Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer. [electronic resource]
Producer: 19950622Description: 42-4 p. digitalISSN:- 0300-8916
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carcinoma, Renal Cell -- therapy
- Drug Administration Schedule
- Drug Synergism
- Female
- Humans
- Injections, Subcutaneous
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Interleukin-2 -- administration & dosage
- Kidney Neoplasms -- therapy
- Male
- Middle Aged
- Recombinant Proteins
- Thymopentin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.